Abstract
Utilization of the Polniaszek reagent Cl2 PNi -Pr2 /AlCl3 was used on amino dienes to generate new azabicyclophosphinic acid as constrained analogues of TPMPA.
Key words
phosphorus - bicyclic compounds - cyclizations - medicinal chemistry - receptors
References
Most recent reviews on GABAC and references herein:
1a
Johnston GAR.
Chebib M.
Hanrahan JR.
Mewett KN.
Curr. Drug Targets: CNS Neurol. Disord.
2003,
2:
260
1b
Johnston GAR.
Curr. Top. Med. Chem.
2002,
2:
903
2
Hanrahan JR.
Mewett KN.
Chebib M.
Burden PM.
Johnston GAR.
J. Chem. Soc., Perkin Trans. 1
2001,
2389
3
Chebib M.
Vandenberg RJ.
Johnston GAR.
Br. J. Pharmacol.
1997,
122:
1551
4
Chebib M.
Chem. Aust.
2001,
68:
19
5
Quin LD.
Middlemas E.
Rao Nandakumar S.
Miller RW.
McPhail AT.
J. Am. Chem. Soc.
1982,
104:
1893
6a
Polniaszek RP.
J. Org. Chem.
1992,
57:
5189
6b
Conway SJ.
Miller JC.
Bond AD.
Clark BP.
Jane DE.
J. Chem. Soc., Perkin Trans. 1
2002,
14:
1625
7
Typical Procedure for Cyclization/Oxidation.
To a suspension of AlCl3 (1.3 g, 10 mmol) in CH2 Cl2 was added dropwise, at -20 °C and under N2 , Cl2 PNi -Pr2 (2.0 g,10 mmol) in CH2 Cl2 . Then, the mixture was stirred at r.t. for 1 h. The mixture was cooled down to -20 °C and N -benzyl diallylamine (936 mg, 5 mmol) in CH2 Cl2 was added dropwise. The mixture was allowed to warm up to r.t., stirred at r.t. for 16 h and refluxed for 1 h. The mixture was cooled down to 0 °C and 10 mL of a solution of 0.2 M EDTA-sat. NaHCO3 (1:1) was added carefully. The mixture was then stirred at r.t. for 5 h. Then, 100 mL of H2 O were added and the aqueous phase was extracted several times with CHCl3 . The organic phases were combined, washed with brine, dried over Na2 SO4 and concentrated in vacuo to afford a crude yellow oil (2 g). Purification was achieved by flash chromatography over silica gel using EtOAc-MeOH (100:0 to 80:20) as eluent. After concentration of the fractions, a yellow paste (1.05 g, 63%) was obtained.
8
1 H NMR (400 MHz, D2 O): δ = 3.55 (m, 2 H), 3.03 (m, 2 H), 2.85 (m, 2 H), 1.82 (m, 2 H), 1.40 (m, 2 H).
9a
Huwe CM.
Blechert S.
Tetrahedron Lett.
1994,
35:
9537
9b
Trost BM.
Chen S.-F.
J. Am. Chem. Soc.
1986,
108:
6053
10 Protocol for purification over DOWEX resin see: Dumond YR.
Montchamp J.-L.
J. Organomet. Chem.
2002,
653:
252
11
1 H NMR (400 MHz, D2 O): δ = 5.87 (d, J = 31.7 Hz, 1 H), 3.79 (d, J = 14.0 Hz, 1 H), 3.56 (d, J = 15.9 Hz, 1 H), 3.42 (dd, J = 12.8 Hz, J = 2.4 Hz, 1 H), 3.01 (m, 1 H), 2.30 (m, 1 H), 2.15 (m, 2 H), 2.00 (m, 1 H), 1.63 (m, 1 H).